Video & Transcript : 'FDA user fees' :

Page 17 of 500
OK

Oklahoma 2026 Regular Session

Business and Insurance 2ND REVISED Apr 16th, 2026 at 09:30 am

Business and Insurance

Transcript Highlights:
  • This is the medical fee schedule. With that, I yield for questions. Do pass from the chair.
  • HB 3041 caps surcharge fees at 4%. With that, I yield for questions.
  • And so, it's talking about processing credit card transactions, talking about the potential fees.
  • If these fees aren't capped, if credit card fees aren't capped at a reasonable rate, everybody else that's
  • The fee schedules are different. The continuing educational requirements are different.
LA

Louisiana 2026 Regular Session

Civil Law and Procedure Apr 13th, 2026

Civil Law and Procedure

Transcript Highlights:
  • and expert witness fees, because Court-approved evaluation fees and expert witness fees, because we
  • wanted to be sure that the expert fees and evaluation fees were back in.
  • A reasonable attorney's fee. And the court-approved evaluation fees and expert witness fees.
  • Amendment will be that it's reasonable attorney's fees and court-approved fees and expert witness fees
  • fees.
Bills: HB27 , HB71 , HB214 , HB225 , HB244 , HB306 , HB366 , HB446 , HB473 , HB514 , HB1043 , HB1082 , SB127
WA

Washington 2025-2026 Regular Session

House Postsecondary Education & Workforce Jan 27th, 2026 at 01:30 pm

Postsecondary Education & Workforce

Transcript Highlights:
  • and a $95 annual renewal fee.
  • Paying these licensing fees means starting a job in debt just to remain employed.
  • And during that time, I paid the licensing fees myself because they were the right thing to do.
  • That wasn't just a fee. That was food, rent, its ability to take away from my family.
  • My question is, if these fees are so burdensome and you... ...question is, if these fees are so burdensome
TX

Texas 89th Regular

Licensing & Administrative Procedures Apr 22nd, 2025

Licensing & Administrative Procedures

AL

Alabama 2025 Regular Session

Alabama House Ways and Means General Fund Committee Feb 19th, 2025

Ways and Means General Fund

Transcript Highlights:
  • Clair County, obviously we are a part of this particular bill, and we get certain monies and fees allocated
  • to the Sheriff's... ...monies and fees allocated to the Sheriff's Office that at this point in time
Bills: HB37 , HB187 , HB177 , SB63 , HB82 , SB48 , HB33 , HB37 , HB33
TX
Transcript Highlights:
  • The FDA at fda.gov said the following. about delta 8 THC.
  • FDA has received adverse reports involving delta 8.
  • I was heavily medicated with a cocktail of FDA approved pharmaceuticals.
  • So FDA criteria is 1,000 parts per million.
  • I'll remind all the senators here that CBD has been FDA approved.
Bills: SB3 , SB810 , SB965 , SB1073 , SB1119 , SB1505 , SB 3
CA

California 2025-2026 Regular Session

Senate Revenue and Taxation Committee Jun 24th, 2026

Revenue and Taxation

Transcript Highlights:
  • The other FDA-authorized vapes previously mentioned...
  • There are 40 FDA-approved devices that could be used with nicotine, so it's one product.
  • , penalties, or interest. under the uncut. a fee, penalties, or interest.
  • The subsequent fees and charges do not reset the clock, and that's important to point out.
  • And employers pay no fees, and they're not fiduciaries.
MN

Minnesota 2025-2026 Regular Session

House Transportation Finance and Policy Committee 3/9/26

Transportation Finance and Policy

Transcript Highlights:
  • Right now, deputy registrars are paid on a per-transaction fee, and that per-transaction fee makes it
  • as part of the authority that's being provided in the bill for setting a fee. around fee setting and
  • </c> institute a fee or increase a fee institute a fee or increase a fee without<00:59:41.200><c> approval
  • </c> department to set a fee for this. department to set a fee for this.
  • , we don't have tab fees anymore.
Bills: HF3919 , HF1335 , HF3864 , HF3916 , HF3728
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Cannabis Policy Jun 21st, 2026 at 10:30 am

Joint Committee on Cannabis Policy

Transcript Highlights:
  • They face no additional tax impositions, no host community agreements, no recall process, no FDA testing
  • No recall process, no FDA testing requirements, no age limits, and, as Commonwealth Beacon has reported
  • the potential users are fully informed.
  • Data from the Sanbrook Research International... ...the potential users are fully informed.
  • The FDA prohibits any sort of hemp edibles, and so does the DPH here.
Summary: The Joint Committee on Cannabis Policy held a hearing on a broad set of cannabis and hemp bills, with the chairs opening by emphasizing unfinished work on equity, public health, safety, and market stability. The committee heard testimony on House Bill 146, which would create more efficient cannabis testing standards by increasing batch sizes, reducing or eliminating some environmental testing, standardizing lab reporting, and requiring annual scientific review and public data reporting. Industry witnesses, including a representative of the Massachusetts Cannabis Coalition, cultivators, and a testing lab owner, said current testing rules are overly burdensome, costly, and inconsistent, and argued the bill would lower compliance costs while preserving consumer safety. A testing lab witness also said some operators switch labs to obtain higher THC results or pass contaminated batches, and urged greater transparency and better sampling protocols. A major portion of the hearing focused on intoxicating hemp and related bills that would bring hemp-derived intoxicating products under a stronger regulatory framework. Legislators and industry witnesses described products sold in gas stations, smoke shops, and convenience stores as often untested, not age-gated, and sometimes mislabeled or far above the federal hemp THC threshold. Testimony from attorneys and cannabis business leaders said states can regulate these products more strictly under the Farm Bill’s non-preemption language, and pointed to New Jersey and other states as possible models. Some witnesses and committee members stressed that any new rules should avoid harming non-intoxicating CBD businesses or lawful hemp farmers, while others argued that the products are effectively cannabis and should be regulated like cannabis for licensing, testing, age limits, and taxation. The committee also heard extensive public-health testimony in support of bills S. 95, S. 96, S. 97 and their House counterparts H. 191, H. 192, and H. 193. Parents, advocates, and public health professionals urged stronger warning labels, THC potency caps, and improved data collection on cannabis-related harms, citing cannabis-induced psychosis, addiction, anxiety, and youth exposure to high-potency products. Several witnesses said Massachusetts has not done enough to track health outcomes or warn consumers, and referenced other jurisdictions such as Connecticut, Vermont, Colorado, Canada, and Quebec as examples of stronger limits or warnings. No votes or formal actions were taken during the hearing; the committee primarily received testimony and questions.
KY
Transcript Highlights:
  • These are not user, "Please die." These are not theoretical<00:04:00.159><c> risks.
  • Listen to users' conversations or interact directly with them.
  • Information about how the AI model is trained should be fully transparent to the user.
  • Information about how the AI model is trained should be fully transparent to the user.
  • And so I think there may be some urgency to not wait for the FDA to catch up.
Summary: The committee met with a quorum, approved the prior meeting minutes, and then heard testimony on the use of artificial intelligence in therapy and mental health settings. Representative Lisa Willner and Brenda Rosen of NASW Kentucky argued for “guard rails” on AI chatbots so they cannot present themselves as licensed therapists or replace school counselors, psychologists, or social workers. They said AI can support licensed professionals, but warned that chatbots cannot reliably recognize nonverbal cues, escalate crises, or provide accountable care, and they cited examples of harmful chatbot interactions, including a suicide case and a chatbot telling a user to “Please die.” The witnesses also raised concerns about data privacy, commercialization of sensitive mental health conversations, and the use of personal clinical content to train AI models. They said minors should require parental consent and suggested transparency about how a chatbot is trained and who created it. They distinguished between unvetted consumer chatbots and AI tools that have been scientifically validated or approved as digital therapeutics, noting that some evidence-based tools may be useful for specific conditions such as depression, anxiety, or eating disorders. Committee members asked whether regulation should be handled by the legislature or by professional boards, and whether a multi-state model would be preferable to 50 different state approaches. The witnesses generally favored expert-led standards and said a board or panel of experts could review and approve mental health chatbots, but members cautioned that boards can become too restrictive and that legislation should preserve flexibility and avoid discouraging children from seeking help. The discussion ended with a request for the witnesses to restate their proposed policy ideas, including privacy protections, bans on commercialization, limits on training AI with clinical content, transparency requirements, and informed consent.
NJ

New Jersey 2026-2027 Regular Session

Assembly Appropriations Jun 23rd, 2026

Transcript Highlights:
  • Repetitive warnings may produce warning fatigue, users tune out, users may tune them out fast.
  • municipality or the mall license fee, both.
  • , including any type of court fees or attorney fees, could go back to the tenant, and that's if the case
  • And then now we want to add an additional fee.
  • This fee, and that... ...of correctional services is subject to a fee.
AZ

Arizona 2026 Regular Session

01/26/2026 - House Land, Agriculture & Rural Affairs

Land, Agriculture & Rural Affairs

Transcript Highlights:
  • , there are currently five consumer products that have completed pre-market consultations under the FDA
  • He added that the product is FDA approved, maintained as safe by the U.S. federal government, and that
  • He stated that it is FDA approved and maintained as safe by the U.S. federal government.
  • The chair said he was not sure whether the witness had worked directly with the FDA or USDA, but noted
  • The FDA has approved it.
Bills: HB2155 , HB2156 , HB2162 , HB2762 , HB2791
TX

Texas 89th Regular

Health and Human Services Apr 8th, 2026

Health & Human Services

Transcript Highlights:
  • I'm with FDA Action and I'll just jump right into it.
  • It's wide open fee for service members.
  • It's a sliding fee scale.
  • Those waiver services are in fee-for-service.
  • What other services are still in fee for service.
Summary: The Senate Committee on Health and Human Services convened to discuss interim charges regarding fraud, waste, and abuse in Texas human services, particularly focusing on Medicaid and childcare programs. The meeting highlighted the importance of preventing misuse of taxpayer funds, with testimony from various stakeholders emphasizing the need for increased oversight and accountability in these programs. Key points included the alarming rise in healthcare fraud in other states, the necessity for Texas to enhance its fraud prevention measures, and the potential financial repercussions of failing to meet federal compliance standards. Several committee members expressed concerns about the impact of fraud on vulnerable populations, particularly those relying on Medicaid services. Testimonies from experts underscored the effectiveness of Texas's Office of Inspector General (OIG) in combating fraud, yet pointed out existing vulnerabilities, such as inconsistent enforcement and the need for better data sharing among agencies. The discussion also touched on the challenges faced by hospice care providers, with a significant increase in the number of hospices in Texas raising concerns about quality and oversight. The committee heard from various witnesses, including representatives from health plans and advocacy organizations, who provided insights into the complexities of managing Medicaid and the importance of maintaining program integrity. The meeting concluded with a commitment to further explore legislative solutions to enhance oversight and ensure that resources are directed to those in genuine need.
CA

California 2025-2026 Regular Session

Senate Environmental Quality Committee Jun 17th, 2026

Environmental Quality

Transcript Highlights:
  • Today, only one disposable vape carries full FDA authorization, and there's only a handful permitted
  • We think it is successful in showing how easily users switched over to the reusable vapes.
  • I think there's some products that are FDA-approved. My question is, I think we're...
  • The FDA-approved, I think there's some products that are FDA-approved.
  • My question is, I think one of the FDA-approved products helps people wean off and helps them quit.
CA

California 2025-2026 Regular Session

Assembly Judiciary Committee Apr 14th, 2026

Judiciary

Transcript Highlights:
  • I also thank the author for agreeing to the amendments to remove the fees because I think the fees aspect
  • The fees piece in there really does create that obstacle.
  • The good news is this year's bill does not contain a fee increase and holds the fees flat.
  • As the Chair said, the annual license fee for attorneys is authorized by this bill.
  • As the Chair said, the annual license fee for attorneys is authorized by this bill.
Committee: House Judiciary
US

US Federal 2025-2026 Regular Session

US House Floor Proceedings (Monday, June 23, 2025)

US Federal House Floor Meeting

Transcript Highlights:
  • </c><02:49:18.800><c> for</c> online dating service bans a user for online dating service bans a user
  • </c> fraud, it notifies all the other users fraud, it notifies all the other users who<02:49:22.160><
  • This bill is an important first users.
  • fees from the company to omit certain fees from the calculation<04:33:30.561><c> of</c><04:33:30.879>
  • of acquired fund fees and calculation of acquired fund fees and expenses<04:33:32.879><c> and</c><04